Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

4’-O-Methylresveratrol is a stilbene that has been found in Rumex and has diverse biological activities.1,2,3,4 It inhibits growth of A549, SKOV3, SK-MEL-2, XF498, and HCT15 cancer cells (IC50s = 3.8, 5.7, 3.2, 5.6, and 6.7 µg/ml, respectively).1 4’-O-Methylresveratrol (0.05-0.2 mM) inhibits rabbit platelet aggregation induced by collagen or arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607).2 It scavenges free radicals in a Trolox equivalent antioxidant capacity (TEAC) assay.3 4’-O-Methyresveratrol suppresses RANKL-induced osteoclastic differentiation of murine bone marrow-derived macrophages (BMDMs) and reduces LPS-induced bone loss in mice when administered at a dose of 50 mg/kg.4
WARNING This product is not for human or veterinary use.
1. Antitumor activity of some phenolic components in plants. Arch. Pharm. Res. 17, 42-44 (1994).
2. Anti-
3. Resveratrol and two monomethylated stilbenes from Israeli Rumex bucephalophorus and their antioxidant potential. J. Nat. Prod. 66(9), 1270-1272 (2003).
4. Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss. Int. J. Mol. Med. 42(1), 569-578 (2018).